The Effect of FOsamprenavir/Ritonavir on the Pharmacokinetics of a Single-dose of the Antipsychotic Agent olanZApine (FORZA).
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Fosamprenavir; Olanzapine; Ritonavir
- Indications HIV infections; Schizophrenia
- Focus Pharmacokinetics
- Acronyms FORZA
- 07 Jan 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.